BELLE MATHESON: Open Payments
NPI 1518307552 · NORWAY, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $62 |
| ABBVIE INC. | 1 | $27 |
| Karyopharm Therapeutics Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $19 |
| Celgene Corporation | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| ARRAY BIOPHARMA INC | 1 | $18 |
Products named: LYNPARZA, IMFINZI, ELAHERE, XPOVIO, VECTIBIX, REVUFORJ, PYLARIFY, REBLOZYL.
Industry payments across ME — which companies pay providers there.
